Home/Pipeline/MSC‑OA

MSC‑OA

Osteoarthritis

Phase 1Active

Key Facts

Indication

Osteoarthritis

Phase

Phase 1

Status

Active

Company

About Advancells

India’s leading GMP‑compliant stem‑cell and exosome therapy provider for personalized regenerative medicine.

View full company profile

Therapeutic Areas

Regenerative Medicine Neurology Orthopedics Dermatology Reproductive Health Ophthalmology

Other Osteoarthritis Drugs

Drug	Company	Phase	Status
Osteoarthritis program	Risen Pharma Tech	Clinical (China & US)	Active
ViscoCell™ for Osteoarthritis	Likarda	Pre-clinical	Active
Osteoarthritis Biologic Therapy	Ageless Biotech	Phase 2b	Active
PKM-011	PK MED	Pre-clinical	Active
CYT-108	Cytonics	Phase 2	Active
Topical PSGAG	ADORA Life Science	Pre-clinical	Active
FGF18 Gene Therapy	Remedium Bio	Pre-clinical	Active
MOTYS™	Doron Therapeutics	Phase 3	Active
Osteoarthritis Treatment Program	Biovico	Pre-clinical	Active
aGF	Scarcell Therapeutics	Phase 1	Active
Cartilage Repair	Sayenza Biosciences	Clinical	Active
BRM521	BRIM Biotechnology	Preclinical	Active